Skip to the page

Data / Form D filings / Thunder Biotech, Inc.

Thunder Biotech, Inc.: Form D filings

Thunder Biotech, Inc., a biotechnology company in Provo, UT, filed 9 Form D notices with the SEC between 2017 and 2024. The latest, on February 26, 2024, reports $100,000 sold of a $2.5 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
395 Cougar Blvd., SUITE 103, Provo, UT, 84604
Phone
(801) 367-9298
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1707315

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 26, 2024New notice$2,500,000$100,000$2,400,0002Feb 9, 2024sec.gov
Oct 17, 2022Amendment$20,000,000$1,000,000$19,000,0001Sep 16, 2022sec.gov
Oct 17, 2022Amendment$20,000,000$1,000,000$19,000,0001Sep 16, 2022sec.gov
Oct 14, 2022New notice$20,000,000$1,000,000$19,000,0001Sep 16, 2022sec.gov
Oct 11, 2022New notice$15,000,000$4,020,000$10,980,00014Nov 30, 2021sec.gov
Aug 22, 2022New notice$10,000,000$8,320,515$1,679,48540Oct 5, 2020sec.gov
Aug 22, 2022New notice$10,000,000$9,979,274$20,72652Sep 30, 2019sec.gov
Nov 6, 2017New notice$18,000,000$325,000$17,675,0003Oct 5, 2017sec.gov
May 23, 2017New notice$2,000,000$770,000$1,230,00010Jan 30, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Kent MisenerDirector
Kim O'NeillExecutive Officer, Director
James BurgessExecutive Officer
Barry MowerDirector
Jeff HoneExecutive Officer, Director
Steven TannerDirector
Scott PetersonDirector
Jeffrey NelsonDirector

Other biotechnology companies in Utah that filed recently

Every Form D from the week of Feb 26, 2024 · All recent filings in Utah · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Thunder Biotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.